SEMAGLUTIDE 2 mg/1.5 mL Pre-filled Pen (Semalix) is a prescription once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It helps regulate blood glucose levels, reduce appetite, and support weight management when combined with a healthy diet and regular exercise. The pre-filled pen provides a convenient method for weekly administration.
| Generic name | SEMAGLUTIDE |
| Strength | 2 mg |
| Manufacturer | Torrent Pharmaceuticals |
| Package size | 1 Single Dose Prefilled Pens of 2 mg/1.5 ml |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
SEMAGLUTIDE 1 mg/0.5 mL (Noveltreat) Injectable Solution is a prescription once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It may also help reduce appetite, support weight management, and lower the risk of certain cardiovascular events in eligible patients when used alongside a healthy diet and regular exercise.
| Generic name | SEMAGLUTIDE |
| Strength | 1 mg |
| Manufacturer | Sun Pharmaceutical |
| Package size | 2 Single Dose Prefilled Pens of 1 mg/0.5 ml |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
MOUNJARO KwikPen (Tirzepatide) 15 mg/0.6 mL is a prescription once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, support weight management, and reduce appetite when combined with a healthy diet and regular physical activity.
| Generic name | Tirzepatide |
| Strength | 15 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
MOUNJARO KwikPen (Tirzepatide) 10 mg/0.6 mL is a prescription injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, support weight management, and reduce appetite when used alongside a healthy diet and regular exercise.
| Generic name | Tirzepatide |
| Strength | 10 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
MOUNJARO KwikPen (Tirzepatide) 7.5 mg/0.6 mL is a prescription once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, reduce appetite, and support weight management when combined with a healthy diet and regular exercise. The 7.5 mg dose is typically prescribed as a maintenance dose based on individual treatment needs.
| Generic name | Tirzepatide |
| Strength | 7.5 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
MOUNJARO KwikPen (Tirzepatide) 5 mg/0.6 mL is a prescription once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, reduce appetite, and support weight management when used alongside a healthy diet and regular exercise. The 5 mg dose is commonly used after the initial 2.5 mg starting dose.
| Generic name | Tirzepatide |
| Strength | 5 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
MOUNJARO KwikPen (Tirzepatide) 2.5 mg/0.6 mL is a prescription once-weekly injectable medicine used as the starting dose for adults beginning treatment for type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve blood sugar control while allowing the body to gradually adjust to the medication. It is typically followed by higher maintenance doses as directed by a healthcare provider.
| Generic name | Tirzepatide |
| Strength | 2.5 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Dapagliflozin 10 mg (Forxiga) is an oral medicine used to treat type 2 diabetes, heart failure, and chronic kidney disease (CKD) in eligible patients. It helps lower blood sugar levels, protects the heart and kidneys, and reduces the risk of disease-related complications when used alongside a healthy diet and lifestyle.
| Generic name | Dapagliflozin |
| Strength | 10 mg |
| Manufacturer | AstraZeneca |
| Package size | 98 Tablets |
| Used for | Type 2 diabetes, heart failure, and chronic kidney disease |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
SAROGLITAZAR 4 mg is a prescription medication used to manage non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) with metabolic dysfunction and diabetic dyslipidemia, particularly elevated triglyceride levels in people with type 2 diabetes. It belongs to the PPAR alpha/gamma agonist class and helps improve lipid metabolism, insulin sensitivity, and liver health when combined with a healthy diet and lifestyle changes.
| Generic name | SAROGLITAZAR |
| Strength | 4 mg |
| Manufacturer | Zydus |
| Package size | 45 Tablets |
| Used for | Diabetic dyslipidemia, hypertriglyceridemia, and type 2 diabetes mellitus |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
